Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05931263 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Randomized Clinical Trial Comparing Chi-BEAM With BEAM Regimen Combined With ASCT for the Treatment of ND PTCL

Name: A Randomized Clinical Trial Comparing Chi-BEAM With BEAM Regimen Combined With ASCT for the Treatment of ND PTCL — clinical trial record (NCT05931263)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusRecruiting

PhasePhase 3

SponsorThe First Affiliated Hospital with Nanjing Medical University

Started2023-06-01

View on ClinicalTrials.gov ↗

Record status

This record was last updated July 5, 2023 (before its estimated February 2026 completion). Its status may not reflect the trial's current state.

The First Affiliated Hospital with Nanjing Medical University

275 trials monitored

See 6 trials at risk

Non-Hodgkin Lymphoma

1,512 trials monitored

See 79 trials at risk

The goal of this clinical trial is to compare Chi-BEAM With BEAM Regimen Combined With ASCT for the Treatment of ND PTCL. The main question it aims to answer are: •Whether Chi-BEAM improves patient survival compared to BEAM group Participants will be given BEAM or Chi-BEAM before ASCT. Researchers will compare the efficacy and safety of the two groups.

Trial Details

NCT Number	NCT05931263
Lead Sponsor	The First Affiliated Hospital with Nanjing Medical University
Conditions	Newly Diagnosed Peripheral T-cell Lymphoma
Enrollment	104 participants
Start Date	2023-06-01
Primary Completion	2026-02 (estimated)
Study Completion	2028-02 (estimated)
Updated on ClinicalTrials.gov	2023-07-05